Blood test center in Florida

Plexision105 Jan, 2021Health

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision�s CLIA-certified, central laboratory in Pittsburgh.

Recent Profiles

Phase V Fulfilment

Phase V Fulfilment

View Profile

Max88

Max88

View Profile

Seattle Nurse Delegation

Seattle Nurse Delegation

View Profile

Goal123

Goal123

View Profile

bet88fitness1

Bet88fitness1

View Profile

Avery Abigail

Avery Abigail

View Profile

Arcara Psychiatry

Arcara Psychiatry

View Profile

kuwin103 com

Kuwin103 Com

View Profile

Local Business Discovery System

Local Business Discovery System

View Profile